Global Ketorolac Injection Supply, Demand and Key Producers, 2026-2032
The global Ketorolac Injection market size is expected to reach $ 201 million by 2032, rising at a market growth of 2.6% CAGR during the forecast period (2026-2032).
Ketorolac tromethamine injection is a prescription injectable nonsteroidal anti-inflammatory drug (NSAID) for short-term analgesia. Its active ingredient is a salt formed from ketorolac and tromethamine. It exerts its analgesic effect (and also has some anti-inflammatory and antipyretic properties) primarily by inhibiting cyclooxygenase (COX) to reduce prostaglandin production. This drug is typically used for short-term treatment of moderate to severe acute pain (commonly in perioperative or emergency pain management). It is characterized by its strong analgesic effect and reduced need for opioids. However, like other NSAIDs, it carries important safety risks such as gastrointestinal bleeding/ulceration, renal impairment, and bleeding. Therefore, strict control of the course of treatment and dosage is emphasized in clinical practice, and it must be used according to contraindications (such as active gastrointestinal bleeding, severe renal insufficiency, and high perioperative bleeding risk).
The demand for ketorolac tromethamine injection is essentially driven by the scenario of 'short-term, intensive analgesia in hospitals.' At the label level, it is positioned as a short-term (maximum of 5 days for adults) tool for managing moderate to severe acute pain, achieving 'opioid-level analgesia requirements,' which aligns particularly well with the clinical pathways for perioperative and emergency acute pain. Simultaneously, the massive number of surgeries performed globally each year and the continuous standardization of perioperative management have made 'opioid-free/multimodal analgesia to reduce opioid use' a long-term trend, providing structural support for NSAID-based injectable analgesia. However, the market expansion of this product is naturally limited by its risk profile: the label explicitly emphasizes several important contraindications and warnings, including renal risk, bleeding risk, and contraindication in CABG surgery. Hospital medication management will more strongly constrain its use within the boundaries of 'short treatment course, controllable population, and monitorable risk.'
From a competitive landscape perspective, ketorolac injection represents a typical combination of a 'mature, generic product + high barriers to entry in sterile injectable manufacturing': brand differentiation is limited, with competition primarily focused on sterile production and quality system capabilities, stable supply capabilities, packaging formats, and hospital compliance support (such as single-dose vials, barcodes and hospital dispensing friendliness, and channel coverage). In markets like the US, publicly available data shows that this product is supplied by multiple companies under different NDC/packaging company identities, including large generic injectable platforms (such as Pfizer and Fresenius Kabi) as well as multiple generic drug companies and packaging/distribution entities (such as Sun and Sagent), reflecting a multi-layered supply chain and price competition. For buyers (hospitals/group purchasing), evaluation dimensions often shift from 'efficacy differences' to 'supply disruption risk, compliance documentation, batch-to-batch consistency, and recall and change control history,' which explains why manufacturing and quality management are given greater emphasis in procurement and market access for this type of product.
North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.
Future growth is more likely to stem from changes in 'clinical pathways and delivery methods' rather than new selling points at the pharmacological level. On the one hand, the strengthening of multimodal analgesia in guidelines and academic consensus will drive hospitals to continuously optimize perioperative analgesia combinations and increase the weighting of non-opioid analgesia. Evidence is also accumulating regarding the effectiveness of NSAIDs in reducing postoperative pain and opioid usage when combined with regional anesthesia and glucocorticoids. On the other hand, safety and compliance requirements will continue to shape the market: the 5-day treatment limit and warnings about bleeding/kidney risk make it more suitable as a short-term tool rather than a long-term medication. Hospitals may place greater emphasis on tiered medication, perioperative bleeding risk management, and kidney function monitoring, thereby prompting companies to invest more in compliance with instructions, risk communication, and real-world medication management support. Meanwhile, given the frequent disruptions to the sterile injectable supply chain, suppliers that can provide more 'ready-to-use/less error-prone' packaging specifications and have stable production capacity and consistent quality have a greater chance of gaining an advantage in centralized procurement/hospital access.
This report studies the global Ketorolac Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Ketorolac Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ketorolac Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Ketorolac Injection total production and demand, 2021-2032, (K Units)
Global Ketorolac Injection total production value, 2021-2032, (USD Million)
Global Ketorolac Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Ketorolac Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Ketorolac Injection domestic production, consumption, key domestic manufacturers and share
Global Ketorolac Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Ketorolac Injection production by Concentration, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Ketorolac Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Ketorolac Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Fresenius Kabi, Sun Pharmaceutical, Sagent Pharmaceuticals, Baxter, Glenmark Pharmaceutical, Sola Pharmaceutical, TC Pharmaceuticals (Jiangsu) Co., Ltd, Lunan Pharm, Yunnan Longhai Natured Plant Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ketorolac Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Concentration, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Ketorolac Injection Market, By Region:
1. How big is the global Ketorolac Injection market?
2. What is the demand of the global Ketorolac Injection market?
3. What is the year over year growth of the global Ketorolac Injection market?
4. What is the production and production value of the global Ketorolac Injection market?
5. Who are the key producers in the global Ketorolac Injection market?
6. What are the growth factors driving the market demand?
Ketorolac tromethamine injection is a prescription injectable nonsteroidal anti-inflammatory drug (NSAID) for short-term analgesia. Its active ingredient is a salt formed from ketorolac and tromethamine. It exerts its analgesic effect (and also has some anti-inflammatory and antipyretic properties) primarily by inhibiting cyclooxygenase (COX) to reduce prostaglandin production. This drug is typically used for short-term treatment of moderate to severe acute pain (commonly in perioperative or emergency pain management). It is characterized by its strong analgesic effect and reduced need for opioids. However, like other NSAIDs, it carries important safety risks such as gastrointestinal bleeding/ulceration, renal impairment, and bleeding. Therefore, strict control of the course of treatment and dosage is emphasized in clinical practice, and it must be used according to contraindications (such as active gastrointestinal bleeding, severe renal insufficiency, and high perioperative bleeding risk).
The demand for ketorolac tromethamine injection is essentially driven by the scenario of 'short-term, intensive analgesia in hospitals.' At the label level, it is positioned as a short-term (maximum of 5 days for adults) tool for managing moderate to severe acute pain, achieving 'opioid-level analgesia requirements,' which aligns particularly well with the clinical pathways for perioperative and emergency acute pain. Simultaneously, the massive number of surgeries performed globally each year and the continuous standardization of perioperative management have made 'opioid-free/multimodal analgesia to reduce opioid use' a long-term trend, providing structural support for NSAID-based injectable analgesia. However, the market expansion of this product is naturally limited by its risk profile: the label explicitly emphasizes several important contraindications and warnings, including renal risk, bleeding risk, and contraindication in CABG surgery. Hospital medication management will more strongly constrain its use within the boundaries of 'short treatment course, controllable population, and monitorable risk.'
From a competitive landscape perspective, ketorolac injection represents a typical combination of a 'mature, generic product + high barriers to entry in sterile injectable manufacturing': brand differentiation is limited, with competition primarily focused on sterile production and quality system capabilities, stable supply capabilities, packaging formats, and hospital compliance support (such as single-dose vials, barcodes and hospital dispensing friendliness, and channel coverage). In markets like the US, publicly available data shows that this product is supplied by multiple companies under different NDC/packaging company identities, including large generic injectable platforms (such as Pfizer and Fresenius Kabi) as well as multiple generic drug companies and packaging/distribution entities (such as Sun and Sagent), reflecting a multi-layered supply chain and price competition. For buyers (hospitals/group purchasing), evaluation dimensions often shift from 'efficacy differences' to 'supply disruption risk, compliance documentation, batch-to-batch consistency, and recall and change control history,' which explains why manufacturing and quality management are given greater emphasis in procurement and market access for this type of product.
North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.
Future growth is more likely to stem from changes in 'clinical pathways and delivery methods' rather than new selling points at the pharmacological level. On the one hand, the strengthening of multimodal analgesia in guidelines and academic consensus will drive hospitals to continuously optimize perioperative analgesia combinations and increase the weighting of non-opioid analgesia. Evidence is also accumulating regarding the effectiveness of NSAIDs in reducing postoperative pain and opioid usage when combined with regional anesthesia and glucocorticoids. On the other hand, safety and compliance requirements will continue to shape the market: the 5-day treatment limit and warnings about bleeding/kidney risk make it more suitable as a short-term tool rather than a long-term medication. Hospitals may place greater emphasis on tiered medication, perioperative bleeding risk management, and kidney function monitoring, thereby prompting companies to invest more in compliance with instructions, risk communication, and real-world medication management support. Meanwhile, given the frequent disruptions to the sterile injectable supply chain, suppliers that can provide more 'ready-to-use/less error-prone' packaging specifications and have stable production capacity and consistent quality have a greater chance of gaining an advantage in centralized procurement/hospital access.
This report studies the global Ketorolac Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Ketorolac Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ketorolac Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Ketorolac Injection total production and demand, 2021-2032, (K Units)
Global Ketorolac Injection total production value, 2021-2032, (USD Million)
Global Ketorolac Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Ketorolac Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Ketorolac Injection domestic production, consumption, key domestic manufacturers and share
Global Ketorolac Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Ketorolac Injection production by Concentration, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Ketorolac Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Ketorolac Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Fresenius Kabi, Sun Pharmaceutical, Sagent Pharmaceuticals, Baxter, Glenmark Pharmaceutical, Sola Pharmaceutical, TC Pharmaceuticals (Jiangsu) Co., Ltd, Lunan Pharm, Yunnan Longhai Natured Plant Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ketorolac Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Concentration, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Ketorolac Injection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 15mg/ml
- 30mg/ml
- Hospital
- Clinics
- Others
- Pfizer
- Fresenius Kabi
- Sun Pharmaceutical
- Sagent Pharmaceuticals
- Baxter
- Glenmark Pharmaceutical
- Sola Pharmaceutical
- TC Pharmaceuticals (Jiangsu) Co., Ltd
- Lunan Pharm
- Yunnan Longhai Natured Plant Pharmaceutical
- Hairon Pharma
- Sichuan Medcalo
- Chengdu Brilliant Pharmaceuticals
- Yung Shin Pharm
- Tianjin Chase Sun Pharmaceutical
- ZISKA Pharmaceuticals
1. How big is the global Ketorolac Injection market?
2. What is the demand of the global Ketorolac Injection market?
3. What is the year over year growth of the global Ketorolac Injection market?
4. What is the production and production value of the global Ketorolac Injection market?
5. Who are the key producers in the global Ketorolac Injection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Ketorolac Injection Introduction
1.2 World Ketorolac Injection Supply & Forecast
1.2.1 World Ketorolac Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Ketorolac Injection Production (2021-2032)
1.2.3 World Ketorolac Injection Pricing Trends (2021-2032)
1.3 World Ketorolac Injection Production by Region (Based on Production Site)
1.3.1 World Ketorolac Injection Production Value by Region (2021-2032)
1.3.2 World Ketorolac Injection Production by Region (2021-2032)
1.3.3 World Ketorolac Injection Average Price by Region (2021-2032)
1.3.4 North America Ketorolac Injection Production (2021-2032)
1.3.5 Europe Ketorolac Injection Production (2021-2032)
1.3.6 China Ketorolac Injection Production (2021-2032)
1.3.7 India Ketorolac Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Ketorolac Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Ketorolac Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Ketorolac Injection Demand (2021-2032)
2.2 World Ketorolac Injection Consumption by Region
2.2.1 World Ketorolac Injection Consumption by Region (2021-2026)
2.2.2 World Ketorolac Injection Consumption Forecast by Region (2027-2032)
2.3 United States Ketorolac Injection Consumption (2021-2032)
2.4 China Ketorolac Injection Consumption (2021-2032)
2.5 Europe Ketorolac Injection Consumption (2021-2032)
2.6 Japan Ketorolac Injection Consumption (2021-2032)
2.7 South Korea Ketorolac Injection Consumption (2021-2032)
2.8 ASEAN Ketorolac Injection Consumption (2021-2032)
2.9 India Ketorolac Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Ketorolac Injection Production Value by Manufacturer (2021-2026)
3.2 World Ketorolac Injection Production by Manufacturer (2021-2026)
3.3 World Ketorolac Injection Average Price by Manufacturer (2021-2026)
3.4 Ketorolac Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Ketorolac Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Ketorolac Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Ketorolac Injection in 2025
3.6 Ketorolac Injection Market: Overall Company Footprint Analysis
3.6.1 Ketorolac Injection Market: Region Footprint
3.6.2 Ketorolac Injection Market: Company Product Type Footprint
3.6.3 Ketorolac Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Ketorolac Injection Production Value Comparison
4.1.1 United States VS China: Ketorolac Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Ketorolac Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Ketorolac Injection Production Comparison
4.2.1 United States VS China: Ketorolac Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Ketorolac Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Ketorolac Injection Consumption Comparison
4.3.1 United States VS China: Ketorolac Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Ketorolac Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Ketorolac Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Ketorolac Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Ketorolac Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Ketorolac Injection Production (2021-2026)
4.5 China Based Ketorolac Injection Manufacturers and Market Share
4.5.1 China Based Ketorolac Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Ketorolac Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Ketorolac Injection Production (2021-2026)
4.6 Rest of World Based Ketorolac Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Ketorolac Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Ketorolac Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Ketorolac Injection Production (2021-2026)
5 MARKET ANALYSIS BY CONCENTRATION
5.1 World Ketorolac Injection Market Size Overview by Concentration: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Concentration
5.2.1 15mg/ml
5.2.2 30mg/ml
5.3 Market Segment by Concentration
5.3.1 World Ketorolac Injection Production by Concentration (2021-2032)
5.3.2 World Ketorolac Injection Production Value by Concentration (2021-2032)
5.3.3 World Ketorolac Injection Average Price by Concentration (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Ketorolac Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Ketorolac Injection Production by Application (2021-2032)
6.3.2 World Ketorolac Injection Production Value by Application (2021-2032)
6.3.3 World Ketorolac Injection Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Ketorolac Injection Product and Services
7.1.4 Pfizer Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Fresenius Kabi
7.2.1 Fresenius Kabi Details
7.2.2 Fresenius Kabi Major Business
7.2.3 Fresenius Kabi Ketorolac Injection Product and Services
7.2.4 Fresenius Kabi Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 Fresenius Kabi Recent Developments/Updates
7.2.6 Fresenius Kabi Competitive Strengths & Weaknesses
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Details
7.3.2 Sun Pharmaceutical Major Business
7.3.3 Sun Pharmaceutical Ketorolac Injection Product and Services
7.3.4 Sun Pharmaceutical Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 Sun Pharmaceutical Recent Developments/Updates
7.3.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
7.4 Sagent Pharmaceuticals
7.4.1 Sagent Pharmaceuticals Details
7.4.2 Sagent Pharmaceuticals Major Business
7.4.3 Sagent Pharmaceuticals Ketorolac Injection Product and Services
7.4.4 Sagent Pharmaceuticals Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Sagent Pharmaceuticals Recent Developments/Updates
7.4.6 Sagent Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Baxter
7.5.1 Baxter Details
7.5.2 Baxter Major Business
7.5.3 Baxter Ketorolac Injection Product and Services
7.5.4 Baxter Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 Baxter Recent Developments/Updates
7.5.6 Baxter Competitive Strengths & Weaknesses
7.6 Glenmark Pharmaceutical
7.6.1 Glenmark Pharmaceutical Details
7.6.2 Glenmark Pharmaceutical Major Business
7.6.3 Glenmark Pharmaceutical Ketorolac Injection Product and Services
7.6.4 Glenmark Pharmaceutical Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 Glenmark Pharmaceutical Recent Developments/Updates
7.6.6 Glenmark Pharmaceutical Competitive Strengths & Weaknesses
7.7 Sola Pharmaceutical
7.7.1 Sola Pharmaceutical Details
7.7.2 Sola Pharmaceutical Major Business
7.7.3 Sola Pharmaceutical Ketorolac Injection Product and Services
7.7.4 Sola Pharmaceutical Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 Sola Pharmaceutical Recent Developments/Updates
7.7.6 Sola Pharmaceutical Competitive Strengths & Weaknesses
7.8 TC Pharmaceuticals (Jiangsu) Co., Ltd
7.8.1 TC Pharmaceuticals (Jiangsu) Co., Ltd Details
7.8.2 TC Pharmaceuticals (Jiangsu) Co., Ltd Major Business
7.8.3 TC Pharmaceuticals (Jiangsu) Co., Ltd Ketorolac Injection Product and Services
7.8.4 TC Pharmaceuticals (Jiangsu) Co., Ltd Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 TC Pharmaceuticals (Jiangsu) Co., Ltd Recent Developments/Updates
7.8.6 TC Pharmaceuticals (Jiangsu) Co., Ltd Competitive Strengths & Weaknesses
7.9 Lunan Pharm
7.9.1 Lunan Pharm Details
7.9.2 Lunan Pharm Major Business
7.9.3 Lunan Pharm Ketorolac Injection Product and Services
7.9.4 Lunan Pharm Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 Lunan Pharm Recent Developments/Updates
7.9.6 Lunan Pharm Competitive Strengths & Weaknesses
7.10 Yunnan Longhai Natured Plant Pharmaceutical
7.10.1 Yunnan Longhai Natured Plant Pharmaceutical Details
7.10.2 Yunnan Longhai Natured Plant Pharmaceutical Major Business
7.10.3 Yunnan Longhai Natured Plant Pharmaceutical Ketorolac Injection Product and Services
7.10.4 Yunnan Longhai Natured Plant Pharmaceutical Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 Yunnan Longhai Natured Plant Pharmaceutical Recent Developments/Updates
7.10.6 Yunnan Longhai Natured Plant Pharmaceutical Competitive Strengths & Weaknesses
7.11 Hairon Pharma
7.11.1 Hairon Pharma Details
7.11.2 Hairon Pharma Major Business
7.11.3 Hairon Pharma Ketorolac Injection Product and Services
7.11.4 Hairon Pharma Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 Hairon Pharma Recent Developments/Updates
7.11.6 Hairon Pharma Competitive Strengths & Weaknesses
7.12 Sichuan Medcalo
7.12.1 Sichuan Medcalo Details
7.12.2 Sichuan Medcalo Major Business
7.12.3 Sichuan Medcalo Ketorolac Injection Product and Services
7.12.4 Sichuan Medcalo Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.12.5 Sichuan Medcalo Recent Developments/Updates
7.12.6 Sichuan Medcalo Competitive Strengths & Weaknesses
7.13 Chengdu Brilliant Pharmaceuticals
7.13.1 Chengdu Brilliant Pharmaceuticals Details
7.13.2 Chengdu Brilliant Pharmaceuticals Major Business
7.13.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product and Services
7.13.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.13.5 Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
7.13.6 Chengdu Brilliant Pharmaceuticals Competitive Strengths & Weaknesses
7.14 Yung Shin Pharm
7.14.1 Yung Shin Pharm Details
7.14.2 Yung Shin Pharm Major Business
7.14.3 Yung Shin Pharm Ketorolac Injection Product and Services
7.14.4 Yung Shin Pharm Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.14.5 Yung Shin Pharm Recent Developments/Updates
7.14.6 Yung Shin Pharm Competitive Strengths & Weaknesses
7.15 Tianjin Chase Sun Pharmaceutical
7.15.1 Tianjin Chase Sun Pharmaceutical Details
7.15.2 Tianjin Chase Sun Pharmaceutical Major Business
7.15.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product and Services
7.15.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.15.5 Tianjin Chase Sun Pharmaceutical Recent Developments/Updates
7.15.6 Tianjin Chase Sun Pharmaceutical Competitive Strengths & Weaknesses
7.16 ZISKA Pharmaceuticals
7.16.1 ZISKA Pharmaceuticals Details
7.16.2 ZISKA Pharmaceuticals Major Business
7.16.3 ZISKA Pharmaceuticals Ketorolac Injection Product and Services
7.16.4 ZISKA Pharmaceuticals Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.16.5 ZISKA Pharmaceuticals Recent Developments/Updates
7.16.6 ZISKA Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Ketorolac Injection Industry Chain
8.2 Ketorolac Injection Upstream Analysis
8.2.1 Ketorolac Injection Core Raw Materials
8.2.2 Main Manufacturers of Ketorolac Injection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Ketorolac Injection Production Mode
8.6 Ketorolac Injection Procurement Model
8.7 Ketorolac Injection Industry Sales Model and Sales Channels
8.7.1 Ketorolac Injection Sales Model
8.7.2 Ketorolac Injection Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Ketorolac Injection Introduction
1.2 World Ketorolac Injection Supply & Forecast
1.2.1 World Ketorolac Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Ketorolac Injection Production (2021-2032)
1.2.3 World Ketorolac Injection Pricing Trends (2021-2032)
1.3 World Ketorolac Injection Production by Region (Based on Production Site)
1.3.1 World Ketorolac Injection Production Value by Region (2021-2032)
1.3.2 World Ketorolac Injection Production by Region (2021-2032)
1.3.3 World Ketorolac Injection Average Price by Region (2021-2032)
1.3.4 North America Ketorolac Injection Production (2021-2032)
1.3.5 Europe Ketorolac Injection Production (2021-2032)
1.3.6 China Ketorolac Injection Production (2021-2032)
1.3.7 India Ketorolac Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Ketorolac Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Ketorolac Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Ketorolac Injection Demand (2021-2032)
2.2 World Ketorolac Injection Consumption by Region
2.2.1 World Ketorolac Injection Consumption by Region (2021-2026)
2.2.2 World Ketorolac Injection Consumption Forecast by Region (2027-2032)
2.3 United States Ketorolac Injection Consumption (2021-2032)
2.4 China Ketorolac Injection Consumption (2021-2032)
2.5 Europe Ketorolac Injection Consumption (2021-2032)
2.6 Japan Ketorolac Injection Consumption (2021-2032)
2.7 South Korea Ketorolac Injection Consumption (2021-2032)
2.8 ASEAN Ketorolac Injection Consumption (2021-2032)
2.9 India Ketorolac Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Ketorolac Injection Production Value by Manufacturer (2021-2026)
3.2 World Ketorolac Injection Production by Manufacturer (2021-2026)
3.3 World Ketorolac Injection Average Price by Manufacturer (2021-2026)
3.4 Ketorolac Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Ketorolac Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Ketorolac Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Ketorolac Injection in 2025
3.6 Ketorolac Injection Market: Overall Company Footprint Analysis
3.6.1 Ketorolac Injection Market: Region Footprint
3.6.2 Ketorolac Injection Market: Company Product Type Footprint
3.6.3 Ketorolac Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Ketorolac Injection Production Value Comparison
4.1.1 United States VS China: Ketorolac Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Ketorolac Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Ketorolac Injection Production Comparison
4.2.1 United States VS China: Ketorolac Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Ketorolac Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Ketorolac Injection Consumption Comparison
4.3.1 United States VS China: Ketorolac Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Ketorolac Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Ketorolac Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Ketorolac Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Ketorolac Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Ketorolac Injection Production (2021-2026)
4.5 China Based Ketorolac Injection Manufacturers and Market Share
4.5.1 China Based Ketorolac Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Ketorolac Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Ketorolac Injection Production (2021-2026)
4.6 Rest of World Based Ketorolac Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Ketorolac Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Ketorolac Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Ketorolac Injection Production (2021-2026)
5 MARKET ANALYSIS BY CONCENTRATION
5.1 World Ketorolac Injection Market Size Overview by Concentration: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Concentration
5.2.1 15mg/ml
5.2.2 30mg/ml
5.3 Market Segment by Concentration
5.3.1 World Ketorolac Injection Production by Concentration (2021-2032)
5.3.2 World Ketorolac Injection Production Value by Concentration (2021-2032)
5.3.3 World Ketorolac Injection Average Price by Concentration (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Ketorolac Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Ketorolac Injection Production by Application (2021-2032)
6.3.2 World Ketorolac Injection Production Value by Application (2021-2032)
6.3.3 World Ketorolac Injection Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Ketorolac Injection Product and Services
7.1.4 Pfizer Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Fresenius Kabi
7.2.1 Fresenius Kabi Details
7.2.2 Fresenius Kabi Major Business
7.2.3 Fresenius Kabi Ketorolac Injection Product and Services
7.2.4 Fresenius Kabi Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 Fresenius Kabi Recent Developments/Updates
7.2.6 Fresenius Kabi Competitive Strengths & Weaknesses
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Details
7.3.2 Sun Pharmaceutical Major Business
7.3.3 Sun Pharmaceutical Ketorolac Injection Product and Services
7.3.4 Sun Pharmaceutical Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 Sun Pharmaceutical Recent Developments/Updates
7.3.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
7.4 Sagent Pharmaceuticals
7.4.1 Sagent Pharmaceuticals Details
7.4.2 Sagent Pharmaceuticals Major Business
7.4.3 Sagent Pharmaceuticals Ketorolac Injection Product and Services
7.4.4 Sagent Pharmaceuticals Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Sagent Pharmaceuticals Recent Developments/Updates
7.4.6 Sagent Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Baxter
7.5.1 Baxter Details
7.5.2 Baxter Major Business
7.5.3 Baxter Ketorolac Injection Product and Services
7.5.4 Baxter Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 Baxter Recent Developments/Updates
7.5.6 Baxter Competitive Strengths & Weaknesses
7.6 Glenmark Pharmaceutical
7.6.1 Glenmark Pharmaceutical Details
7.6.2 Glenmark Pharmaceutical Major Business
7.6.3 Glenmark Pharmaceutical Ketorolac Injection Product and Services
7.6.4 Glenmark Pharmaceutical Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 Glenmark Pharmaceutical Recent Developments/Updates
7.6.6 Glenmark Pharmaceutical Competitive Strengths & Weaknesses
7.7 Sola Pharmaceutical
7.7.1 Sola Pharmaceutical Details
7.7.2 Sola Pharmaceutical Major Business
7.7.3 Sola Pharmaceutical Ketorolac Injection Product and Services
7.7.4 Sola Pharmaceutical Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 Sola Pharmaceutical Recent Developments/Updates
7.7.6 Sola Pharmaceutical Competitive Strengths & Weaknesses
7.8 TC Pharmaceuticals (Jiangsu) Co., Ltd
7.8.1 TC Pharmaceuticals (Jiangsu) Co., Ltd Details
7.8.2 TC Pharmaceuticals (Jiangsu) Co., Ltd Major Business
7.8.3 TC Pharmaceuticals (Jiangsu) Co., Ltd Ketorolac Injection Product and Services
7.8.4 TC Pharmaceuticals (Jiangsu) Co., Ltd Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 TC Pharmaceuticals (Jiangsu) Co., Ltd Recent Developments/Updates
7.8.6 TC Pharmaceuticals (Jiangsu) Co., Ltd Competitive Strengths & Weaknesses
7.9 Lunan Pharm
7.9.1 Lunan Pharm Details
7.9.2 Lunan Pharm Major Business
7.9.3 Lunan Pharm Ketorolac Injection Product and Services
7.9.4 Lunan Pharm Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 Lunan Pharm Recent Developments/Updates
7.9.6 Lunan Pharm Competitive Strengths & Weaknesses
7.10 Yunnan Longhai Natured Plant Pharmaceutical
7.10.1 Yunnan Longhai Natured Plant Pharmaceutical Details
7.10.2 Yunnan Longhai Natured Plant Pharmaceutical Major Business
7.10.3 Yunnan Longhai Natured Plant Pharmaceutical Ketorolac Injection Product and Services
7.10.4 Yunnan Longhai Natured Plant Pharmaceutical Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 Yunnan Longhai Natured Plant Pharmaceutical Recent Developments/Updates
7.10.6 Yunnan Longhai Natured Plant Pharmaceutical Competitive Strengths & Weaknesses
7.11 Hairon Pharma
7.11.1 Hairon Pharma Details
7.11.2 Hairon Pharma Major Business
7.11.3 Hairon Pharma Ketorolac Injection Product and Services
7.11.4 Hairon Pharma Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 Hairon Pharma Recent Developments/Updates
7.11.6 Hairon Pharma Competitive Strengths & Weaknesses
7.12 Sichuan Medcalo
7.12.1 Sichuan Medcalo Details
7.12.2 Sichuan Medcalo Major Business
7.12.3 Sichuan Medcalo Ketorolac Injection Product and Services
7.12.4 Sichuan Medcalo Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.12.5 Sichuan Medcalo Recent Developments/Updates
7.12.6 Sichuan Medcalo Competitive Strengths & Weaknesses
7.13 Chengdu Brilliant Pharmaceuticals
7.13.1 Chengdu Brilliant Pharmaceuticals Details
7.13.2 Chengdu Brilliant Pharmaceuticals Major Business
7.13.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product and Services
7.13.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.13.5 Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
7.13.6 Chengdu Brilliant Pharmaceuticals Competitive Strengths & Weaknesses
7.14 Yung Shin Pharm
7.14.1 Yung Shin Pharm Details
7.14.2 Yung Shin Pharm Major Business
7.14.3 Yung Shin Pharm Ketorolac Injection Product and Services
7.14.4 Yung Shin Pharm Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.14.5 Yung Shin Pharm Recent Developments/Updates
7.14.6 Yung Shin Pharm Competitive Strengths & Weaknesses
7.15 Tianjin Chase Sun Pharmaceutical
7.15.1 Tianjin Chase Sun Pharmaceutical Details
7.15.2 Tianjin Chase Sun Pharmaceutical Major Business
7.15.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product and Services
7.15.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.15.5 Tianjin Chase Sun Pharmaceutical Recent Developments/Updates
7.15.6 Tianjin Chase Sun Pharmaceutical Competitive Strengths & Weaknesses
7.16 ZISKA Pharmaceuticals
7.16.1 ZISKA Pharmaceuticals Details
7.16.2 ZISKA Pharmaceuticals Major Business
7.16.3 ZISKA Pharmaceuticals Ketorolac Injection Product and Services
7.16.4 ZISKA Pharmaceuticals Ketorolac Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.16.5 ZISKA Pharmaceuticals Recent Developments/Updates
7.16.6 ZISKA Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Ketorolac Injection Industry Chain
8.2 Ketorolac Injection Upstream Analysis
8.2.1 Ketorolac Injection Core Raw Materials
8.2.2 Main Manufacturers of Ketorolac Injection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Ketorolac Injection Production Mode
8.6 Ketorolac Injection Procurement Model
8.7 Ketorolac Injection Industry Sales Model and Sales Channels
8.7.1 Ketorolac Injection Sales Model
8.7.2 Ketorolac Injection Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Ketorolac Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Ketorolac Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Ketorolac Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Ketorolac Injection Production Value Market Share by Region (2021-2026)
Table 5. World Ketorolac Injection Production Value Market Share by Region (2027-2032)
Table 6. World Ketorolac Injection Production by Region (2021-2026) & (K Units)
Table 7. World Ketorolac Injection Production by Region (2027-2032) & (K Units)
Table 8. World Ketorolac Injection Production Market Share by Region (2021-2026)
Table 9. World Ketorolac Injection Production Market Share by Region (2027-2032)
Table 10. World Ketorolac Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Ketorolac Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Ketorolac Injection Major Market Trends
Table 13. World Ketorolac Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Ketorolac Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Ketorolac Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Ketorolac Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Ketorolac Injection Producers in 2025
Table 18. World Ketorolac Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Ketorolac Injection Producers in 2025
Table 20. World Ketorolac Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Ketorolac Injection Company Evaluation Quadrant
Table 22. World Ketorolac Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Ketorolac Injection Production Site of Key Manufacturer
Table 24. Ketorolac Injection Market: Company Product Type Footprint
Table 25. Ketorolac Injection Market: Company Product Application Footprint
Table 26. Ketorolac Injection Competitive Factors
Table 27. Ketorolac Injection New Entrant and Capacity Expansion Plans
Table 28. Ketorolac Injection Mergers & Acquisitions Activity
Table 29. United States VS China Ketorolac Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Ketorolac Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Ketorolac Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Ketorolac Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Ketorolac Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Ketorolac Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Ketorolac Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Ketorolac Injection Production Market Share (2021-2026)
Table 37. China Based Ketorolac Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Ketorolac Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Ketorolac Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Ketorolac Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Ketorolac Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Ketorolac Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Ketorolac Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Ketorolac Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Ketorolac Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Ketorolac Injection Production Market Share (2021-2026)
Table 47. World Ketorolac Injection Production Value by Concentration, (USD Million), 2021 & 2025 & 2032
Table 48. World Ketorolac Injection Production by Concentration (2021-2026) & (K Units)
Table 49. World Ketorolac Injection Production by Concentration (2027-2032) & (K Units)
Table 50. World Ketorolac Injection Production Value by Concentration (2021-2026) & (USD Million)
Table 51. World Ketorolac Injection Production Value by Concentration (2027-2032) & (USD Million)
Table 52. World Ketorolac Injection Average Price by Concentration (2021-2026) & (US$/Unit)
Table 53. World Ketorolac Injection Average Price by Concentration (2027-2032) & (US$/Unit)
Table 54. World Ketorolac Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Ketorolac Injection Production by Application (2021-2026) & (K Units)
Table 56. World Ketorolac Injection Production by Application (2027-2032) & (K Units)
Table 57. World Ketorolac Injection Production Value by Application (2021-2026) & (USD Million)
Table 58. World Ketorolac Injection Production Value by Application (2027-2032) & (USD Million)
Table 59. World Ketorolac Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 60. World Ketorolac Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Ketorolac Injection Product and Services
Table 64. Pfizer Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 68. Fresenius Kabi Major Business
Table 69. Fresenius Kabi Ketorolac Injection Product and Services
Table 70. Fresenius Kabi Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Fresenius Kabi Recent Developments/Updates
Table 72. Fresenius Kabi Competitive Strengths & Weaknesses
Table 73. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Sun Pharmaceutical Major Business
Table 75. Sun Pharmaceutical Ketorolac Injection Product and Services
Table 76. Sun Pharmaceutical Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Sun Pharmaceutical Recent Developments/Updates
Table 78. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Sagent Pharmaceuticals Major Business
Table 81. Sagent Pharmaceuticals Ketorolac Injection Product and Services
Table 82. Sagent Pharmaceuticals Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Sagent Pharmaceuticals Recent Developments/Updates
Table 84. Sagent Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Baxter Basic Information, Manufacturing Base and Competitors
Table 86. Baxter Major Business
Table 87. Baxter Ketorolac Injection Product and Services
Table 88. Baxter Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Baxter Recent Developments/Updates
Table 90. Baxter Competitive Strengths & Weaknesses
Table 91. Glenmark Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Glenmark Pharmaceutical Major Business
Table 93. Glenmark Pharmaceutical Ketorolac Injection Product and Services
Table 94. Glenmark Pharmaceutical Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Glenmark Pharmaceutical Recent Developments/Updates
Table 96. Glenmark Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Sola Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Sola Pharmaceutical Major Business
Table 99. Sola Pharmaceutical Ketorolac Injection Product and Services
Table 100. Sola Pharmaceutical Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Sola Pharmaceutical Recent Developments/Updates
Table 102. Sola Pharmaceutical Competitive Strengths & Weaknesses
Table 103. TC Pharmaceuticals (Jiangsu) Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. TC Pharmaceuticals (Jiangsu) Co., Ltd Major Business
Table 105. TC Pharmaceuticals (Jiangsu) Co., Ltd Ketorolac Injection Product and Services
Table 106. TC Pharmaceuticals (Jiangsu) Co., Ltd Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. TC Pharmaceuticals (Jiangsu) Co., Ltd Recent Developments/Updates
Table 108. TC Pharmaceuticals (Jiangsu) Co., Ltd Competitive Strengths & Weaknesses
Table 109. Lunan Pharm Basic Information, Manufacturing Base and Competitors
Table 110. Lunan Pharm Major Business
Table 111. Lunan Pharm Ketorolac Injection Product and Services
Table 112. Lunan Pharm Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Lunan Pharm Recent Developments/Updates
Table 114. Lunan Pharm Competitive Strengths & Weaknesses
Table 115. Yunnan Longhai Natured Plant Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Yunnan Longhai Natured Plant Pharmaceutical Major Business
Table 117. Yunnan Longhai Natured Plant Pharmaceutical Ketorolac Injection Product and Services
Table 118. Yunnan Longhai Natured Plant Pharmaceutical Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Yunnan Longhai Natured Plant Pharmaceutical Recent Developments/Updates
Table 120. Yunnan Longhai Natured Plant Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Hairon Pharma Basic Information, Manufacturing Base and Competitors
Table 122. Hairon Pharma Major Business
Table 123. Hairon Pharma Ketorolac Injection Product and Services
Table 124. Hairon Pharma Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Hairon Pharma Recent Developments/Updates
Table 126. Hairon Pharma Competitive Strengths & Weaknesses
Table 127. Sichuan Medcalo Basic Information, Manufacturing Base and Competitors
Table 128. Sichuan Medcalo Major Business
Table 129. Sichuan Medcalo Ketorolac Injection Product and Services
Table 130. Sichuan Medcalo Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Sichuan Medcalo Recent Developments/Updates
Table 132. Sichuan Medcalo Competitive Strengths & Weaknesses
Table 133. Chengdu Brilliant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 134. Chengdu Brilliant Pharmaceuticals Major Business
Table 135. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product and Services
Table 136. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
Table 138. Chengdu Brilliant Pharmaceuticals Competitive Strengths & Weaknesses
Table 139. Yung Shin Pharm Basic Information, Manufacturing Base and Competitors
Table 140. Yung Shin Pharm Major Business
Table 141. Yung Shin Pharm Ketorolac Injection Product and Services
Table 142. Yung Shin Pharm Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Yung Shin Pharm Recent Developments/Updates
Table 144. Yung Shin Pharm Competitive Strengths & Weaknesses
Table 145. Tianjin Chase Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 146. Tianjin Chase Sun Pharmaceutical Major Business
Table 147. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product and Services
Table 148. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 149. Tianjin Chase Sun Pharmaceutical Recent Developments/Updates
Table 150. Tianjin Chase Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 151. ZISKA Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 152. ZISKA Pharmaceuticals Major Business
Table 153. ZISKA Pharmaceuticals Ketorolac Injection Product and Services
Table 154. ZISKA Pharmaceuticals Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. ZISKA Pharmaceuticals Recent Developments/Updates
Table 156. ZISKA Pharmaceuticals Competitive Strengths & Weaknesses
Table 157. Global Key Players of Ketorolac Injection Upstream (Raw Materials)
Table 158. Global Ketorolac Injection Typical Customers
Table 159. Ketorolac Injection Typical Distributors
Table 1. World Ketorolac Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Ketorolac Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Ketorolac Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Ketorolac Injection Production Value Market Share by Region (2021-2026)
Table 5. World Ketorolac Injection Production Value Market Share by Region (2027-2032)
Table 6. World Ketorolac Injection Production by Region (2021-2026) & (K Units)
Table 7. World Ketorolac Injection Production by Region (2027-2032) & (K Units)
Table 8. World Ketorolac Injection Production Market Share by Region (2021-2026)
Table 9. World Ketorolac Injection Production Market Share by Region (2027-2032)
Table 10. World Ketorolac Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Ketorolac Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Ketorolac Injection Major Market Trends
Table 13. World Ketorolac Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Ketorolac Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Ketorolac Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Ketorolac Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Ketorolac Injection Producers in 2025
Table 18. World Ketorolac Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Ketorolac Injection Producers in 2025
Table 20. World Ketorolac Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Ketorolac Injection Company Evaluation Quadrant
Table 22. World Ketorolac Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Ketorolac Injection Production Site of Key Manufacturer
Table 24. Ketorolac Injection Market: Company Product Type Footprint
Table 25. Ketorolac Injection Market: Company Product Application Footprint
Table 26. Ketorolac Injection Competitive Factors
Table 27. Ketorolac Injection New Entrant and Capacity Expansion Plans
Table 28. Ketorolac Injection Mergers & Acquisitions Activity
Table 29. United States VS China Ketorolac Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Ketorolac Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Ketorolac Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Ketorolac Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Ketorolac Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Ketorolac Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Ketorolac Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Ketorolac Injection Production Market Share (2021-2026)
Table 37. China Based Ketorolac Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Ketorolac Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Ketorolac Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Ketorolac Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Ketorolac Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Ketorolac Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Ketorolac Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Ketorolac Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Ketorolac Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Ketorolac Injection Production Market Share (2021-2026)
Table 47. World Ketorolac Injection Production Value by Concentration, (USD Million), 2021 & 2025 & 2032
Table 48. World Ketorolac Injection Production by Concentration (2021-2026) & (K Units)
Table 49. World Ketorolac Injection Production by Concentration (2027-2032) & (K Units)
Table 50. World Ketorolac Injection Production Value by Concentration (2021-2026) & (USD Million)
Table 51. World Ketorolac Injection Production Value by Concentration (2027-2032) & (USD Million)
Table 52. World Ketorolac Injection Average Price by Concentration (2021-2026) & (US$/Unit)
Table 53. World Ketorolac Injection Average Price by Concentration (2027-2032) & (US$/Unit)
Table 54. World Ketorolac Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Ketorolac Injection Production by Application (2021-2026) & (K Units)
Table 56. World Ketorolac Injection Production by Application (2027-2032) & (K Units)
Table 57. World Ketorolac Injection Production Value by Application (2021-2026) & (USD Million)
Table 58. World Ketorolac Injection Production Value by Application (2027-2032) & (USD Million)
Table 59. World Ketorolac Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 60. World Ketorolac Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Ketorolac Injection Product and Services
Table 64. Pfizer Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 68. Fresenius Kabi Major Business
Table 69. Fresenius Kabi Ketorolac Injection Product and Services
Table 70. Fresenius Kabi Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Fresenius Kabi Recent Developments/Updates
Table 72. Fresenius Kabi Competitive Strengths & Weaknesses
Table 73. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Sun Pharmaceutical Major Business
Table 75. Sun Pharmaceutical Ketorolac Injection Product and Services
Table 76. Sun Pharmaceutical Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Sun Pharmaceutical Recent Developments/Updates
Table 78. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Sagent Pharmaceuticals Major Business
Table 81. Sagent Pharmaceuticals Ketorolac Injection Product and Services
Table 82. Sagent Pharmaceuticals Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Sagent Pharmaceuticals Recent Developments/Updates
Table 84. Sagent Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Baxter Basic Information, Manufacturing Base and Competitors
Table 86. Baxter Major Business
Table 87. Baxter Ketorolac Injection Product and Services
Table 88. Baxter Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Baxter Recent Developments/Updates
Table 90. Baxter Competitive Strengths & Weaknesses
Table 91. Glenmark Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Glenmark Pharmaceutical Major Business
Table 93. Glenmark Pharmaceutical Ketorolac Injection Product and Services
Table 94. Glenmark Pharmaceutical Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Glenmark Pharmaceutical Recent Developments/Updates
Table 96. Glenmark Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Sola Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Sola Pharmaceutical Major Business
Table 99. Sola Pharmaceutical Ketorolac Injection Product and Services
Table 100. Sola Pharmaceutical Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Sola Pharmaceutical Recent Developments/Updates
Table 102. Sola Pharmaceutical Competitive Strengths & Weaknesses
Table 103. TC Pharmaceuticals (Jiangsu) Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. TC Pharmaceuticals (Jiangsu) Co., Ltd Major Business
Table 105. TC Pharmaceuticals (Jiangsu) Co., Ltd Ketorolac Injection Product and Services
Table 106. TC Pharmaceuticals (Jiangsu) Co., Ltd Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. TC Pharmaceuticals (Jiangsu) Co., Ltd Recent Developments/Updates
Table 108. TC Pharmaceuticals (Jiangsu) Co., Ltd Competitive Strengths & Weaknesses
Table 109. Lunan Pharm Basic Information, Manufacturing Base and Competitors
Table 110. Lunan Pharm Major Business
Table 111. Lunan Pharm Ketorolac Injection Product and Services
Table 112. Lunan Pharm Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Lunan Pharm Recent Developments/Updates
Table 114. Lunan Pharm Competitive Strengths & Weaknesses
Table 115. Yunnan Longhai Natured Plant Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Yunnan Longhai Natured Plant Pharmaceutical Major Business
Table 117. Yunnan Longhai Natured Plant Pharmaceutical Ketorolac Injection Product and Services
Table 118. Yunnan Longhai Natured Plant Pharmaceutical Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Yunnan Longhai Natured Plant Pharmaceutical Recent Developments/Updates
Table 120. Yunnan Longhai Natured Plant Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Hairon Pharma Basic Information, Manufacturing Base and Competitors
Table 122. Hairon Pharma Major Business
Table 123. Hairon Pharma Ketorolac Injection Product and Services
Table 124. Hairon Pharma Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Hairon Pharma Recent Developments/Updates
Table 126. Hairon Pharma Competitive Strengths & Weaknesses
Table 127. Sichuan Medcalo Basic Information, Manufacturing Base and Competitors
Table 128. Sichuan Medcalo Major Business
Table 129. Sichuan Medcalo Ketorolac Injection Product and Services
Table 130. Sichuan Medcalo Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Sichuan Medcalo Recent Developments/Updates
Table 132. Sichuan Medcalo Competitive Strengths & Weaknesses
Table 133. Chengdu Brilliant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 134. Chengdu Brilliant Pharmaceuticals Major Business
Table 135. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product and Services
Table 136. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
Table 138. Chengdu Brilliant Pharmaceuticals Competitive Strengths & Weaknesses
Table 139. Yung Shin Pharm Basic Information, Manufacturing Base and Competitors
Table 140. Yung Shin Pharm Major Business
Table 141. Yung Shin Pharm Ketorolac Injection Product and Services
Table 142. Yung Shin Pharm Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Yung Shin Pharm Recent Developments/Updates
Table 144. Yung Shin Pharm Competitive Strengths & Weaknesses
Table 145. Tianjin Chase Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 146. Tianjin Chase Sun Pharmaceutical Major Business
Table 147. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product and Services
Table 148. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 149. Tianjin Chase Sun Pharmaceutical Recent Developments/Updates
Table 150. Tianjin Chase Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 151. ZISKA Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 152. ZISKA Pharmaceuticals Major Business
Table 153. ZISKA Pharmaceuticals Ketorolac Injection Product and Services
Table 154. ZISKA Pharmaceuticals Ketorolac Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. ZISKA Pharmaceuticals Recent Developments/Updates
Table 156. ZISKA Pharmaceuticals Competitive Strengths & Weaknesses
Table 157. Global Key Players of Ketorolac Injection Upstream (Raw Materials)
Table 158. Global Ketorolac Injection Typical Customers
Table 159. Ketorolac Injection Typical Distributors
LIST OF FIGURES
Figure 1. Ketorolac Injection Picture
Figure 2. World Ketorolac Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Ketorolac Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Ketorolac Injection Production (2021-2032) & (K Units)
Figure 5. World Ketorolac Injection Average Price (2021-2032) & (US$/Unit)
Figure 6. World Ketorolac Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Ketorolac Injection Production Market Share by Region (2021-2032)
Figure 8. North America Ketorolac Injection Production (2021-2032) & (K Units)
Figure 9. Europe Ketorolac Injection Production (2021-2032) & (K Units)
Figure 10. China Ketorolac Injection Production (2021-2032) & (K Units)
Figure 11. India Ketorolac Injection Production (2021-2032) & (K Units)
Figure 12. Ketorolac Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 15. World Ketorolac Injection Consumption Market Share by Region (2021-2032)
Figure 16. United States Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 17. China Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 18. Europe Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 19. Japan Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 20. South Korea Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 22. India Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Ketorolac Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Ketorolac Injection Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Ketorolac Injection Markets in 2025
Figure 26. United States VS China: Ketorolac Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Ketorolac Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Ketorolac Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Ketorolac Injection Production Market Share 2025
Figure 30. China Based Manufacturers Ketorolac Injection Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Ketorolac Injection Production Market Share 2025
Figure 32. World Ketorolac Injection Production Value by Concentration, (USD Million), 2021 & 2025 & 2032
Figure 33. World Ketorolac Injection Production Value Market Share by Concentration in 2025
Figure 34. 15mg/ml
Figure 35. 30mg/ml
Figure 36. World Ketorolac Injection Production Market Share by Concentration (2021-2032)
Figure 37. World Ketorolac Injection Production Value Market Share by Concentration (2021-2032)
Figure 38. World Ketorolac Injection Average Price by Concentration (2021-2032) & (US$/Unit)
Figure 39. World Ketorolac Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 40. World Ketorolac Injection Production Value Market Share by Application in 2025
Figure 41. Hospital
Figure 42. Clinics
Figure 43. Others
Figure 44. World Ketorolac Injection Production Market Share by Application (2021-2032)
Figure 45. World Ketorolac Injection Production Value Market Share by Application (2021-2032)
Figure 46. World Ketorolac Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 47. Ketorolac Injection Industry Chain
Figure 48. Ketorolac Injection Procurement Model
Figure 49. Ketorolac Injection Sales Model
Figure 50. Ketorolac Injection Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Ketorolac Injection Picture
Figure 2. World Ketorolac Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Ketorolac Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Ketorolac Injection Production (2021-2032) & (K Units)
Figure 5. World Ketorolac Injection Average Price (2021-2032) & (US$/Unit)
Figure 6. World Ketorolac Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Ketorolac Injection Production Market Share by Region (2021-2032)
Figure 8. North America Ketorolac Injection Production (2021-2032) & (K Units)
Figure 9. Europe Ketorolac Injection Production (2021-2032) & (K Units)
Figure 10. China Ketorolac Injection Production (2021-2032) & (K Units)
Figure 11. India Ketorolac Injection Production (2021-2032) & (K Units)
Figure 12. Ketorolac Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 15. World Ketorolac Injection Consumption Market Share by Region (2021-2032)
Figure 16. United States Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 17. China Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 18. Europe Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 19. Japan Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 20. South Korea Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 22. India Ketorolac Injection Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Ketorolac Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Ketorolac Injection Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Ketorolac Injection Markets in 2025
Figure 26. United States VS China: Ketorolac Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Ketorolac Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Ketorolac Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Ketorolac Injection Production Market Share 2025
Figure 30. China Based Manufacturers Ketorolac Injection Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Ketorolac Injection Production Market Share 2025
Figure 32. World Ketorolac Injection Production Value by Concentration, (USD Million), 2021 & 2025 & 2032
Figure 33. World Ketorolac Injection Production Value Market Share by Concentration in 2025
Figure 34. 15mg/ml
Figure 35. 30mg/ml
Figure 36. World Ketorolac Injection Production Market Share by Concentration (2021-2032)
Figure 37. World Ketorolac Injection Production Value Market Share by Concentration (2021-2032)
Figure 38. World Ketorolac Injection Average Price by Concentration (2021-2032) & (US$/Unit)
Figure 39. World Ketorolac Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 40. World Ketorolac Injection Production Value Market Share by Application in 2025
Figure 41. Hospital
Figure 42. Clinics
Figure 43. Others
Figure 44. World Ketorolac Injection Production Market Share by Application (2021-2032)
Figure 45. World Ketorolac Injection Production Value Market Share by Application (2021-2032)
Figure 46. World Ketorolac Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 47. Ketorolac Injection Industry Chain
Figure 48. Ketorolac Injection Procurement Model
Figure 49. Ketorolac Injection Sales Model
Figure 50. Ketorolac Injection Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
